Comparative efficacy of an optimal exam between ultrasound versus abbreviated <scp>MRI</scp> for <scp>HCC</scp> screening in <scp>NAFLD</scp> cirrhosis: A prospective study-Reference-Cited by-同舟云学术

Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study

Published:2022-02-28 Issue:7 Volume:55 Page:820-827
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Huang Daniel Q.¹²³^ORCID,Fowler Kathryn J.⁴,Liau Joy⁴,Cunha Guilherme M.⁴,Louie Ashley L.⁴,An Julie Y.⁴,Bettencourt Ricki¹,Jung Jinho¹^ORCID,Gitto Zachary¹,Hernandez Christie¹,Lopez Scarlett J.¹,Gupta Hersh¹,Sirlin Claude B.⁴,Marks Robert M.⁵,Loomba Rohit¹⁶^ORCID

Affiliation:

1. NAFLD Research Center, Division of Gastroenterology University of California at San Diego La Jolla California USA

2. Department of Medicine, Yong Loo Lin School of Medicine National University of Singapore Singapore

3. Division of Gastroenterology and Hepatology, Department of Medicine National University Health System Singapore

4. Liver Imaging Group, Department of Radiology University of California San Diego La Jolla California USA

5. Department of Radiology Naval Medical Center San Diego San Diego California USA

6. Division of Epidemiology, Department of Family Medicine and Public Health University of California at San Diego San Diego California USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16844

Reference31 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. The global NAFLD epidemic

3. Mechanisms and disease consequences of nonalcoholic fatty liver disease

4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

5. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Cardiometabolic criteria matters in MASLD;Alimentary Pharmacology & Therapeutics;2024-09-03

2. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09

3. Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy;Supportive Care in Cancer;2024-08-14

4. Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on Ultrasound;Cancers;2024-07-30

5. Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH;Transplantation Direct;2024-06-20